еНаука - преглед
Преглед према Аутор Milella, Michele
Приказ резултата 1 до 6 од 6
| Година | Наслов | Аутор(и) | Тип резултата | Мп-кат. |
|---|---|---|---|---|
| 2012 | Advances in Targeting Signal Transduction Pathways | McCubrey, James A.; Steelman, Linda S.; Chappell, William H.; Sun, Lin; Davis, Nicole M.; Abrams, Stephen L.; Franklin, Richard A.; Cocco, Lucio; Evangelisti, Camilla; Chiarini, Francesca;
Martelli, Alberto M.; Libra, Massimo; Candido, Saverio; Ligresti, Giovanni; Malaponte, Grazia; Mazzarino, Maria C.; Fagone, Paolo; Donia, Marco; Nicoletti, Ferdinando; Polesel, Jerry; Talamini, Renato; Bäsecke, Jörg; Mijatović, Sanja
  ; Maksimović Ivanić, Danijela ; Milella, Michele; Tafuri, Agostino; Dulińska-Litewka, Joanna; Laidler, Piotr; D’Assoro, Antonio B.; Drobot, Lyudmyla; Umezawa, Kazuo; Montalto, Giuseppe; Cervello, Melchiorre; Demidenko, Zoya N.; | Научни чланак | 21aM21a - Рад у међ. часопису изузетних вредности |
| 2012 | Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades Which Alter Therapy Response. | McCubrey, James A; Steelman, Linda S; Chappell, William H; Abrams, Stephen L; Montalto, Giuseppe; Cervello, Melchiorre; Nicoletti, Ferdinando; Fagone, Paolo; Malaponte, Graziella; Mazzarino, Maria C;
Candido, Saverio; Libra, Massimo; Baesecke, Joerg; Mijatović, Sanja
; Maksimović-Ivanić, Danijela ; Milella, Michele; Tafuri, Agostino; Cocco, Lucio; Evangelisti, Camilla; Chiarini, Francesca; Martelli, Alberto M; | Научни чланак | 21aM21a - Рад у међ. часопису изузетних вредности |
| 2015 | Phase II randomized trial of MEK inhibitor pimasertib or placebo combined with gemcitabine in the first-line treatment of metastatic pancreatic cancer. | Van, Cutsem Eric; Hidalgo, Manuel; Bazin, Igor; Canon, Jean-Luc; Poddubskaya, Elena; Manojlovic, Nebojsa S; Milella, Michele; Radenkovic, Dejan V; Verslype, Chris; Guo, Wei;
Damstrup, Lars; Hammel, Pascal;
| Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2012 | Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance | McCubrey, James A; Steelman, Linda S; Chappell, William H; Abrams, Stephen L; Franklin, Richard A; Montalto, Giuseppe; Cervello, Melchiorre; Libra, Massimo; Candido, Saverio; Malaponte, Graziella;
Mazzarino, Maria C; Fagone, Paolo; Nicoletti, Ferdinando; Baesecke, Joerg; Mijatović, Sanja
; Maksimović-Ivanić, Danijela ; Milella, Michele; Tafuri, Agostino; Chiarini, Francesca; Evangelisti, Camilla; Cocco, Lucio; Martelli, Alberto M; | Научна критика и полемика | 21aM21a - Рад у међ. часопису изузетних вредности |
| 2011 | Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health | Chappell, William H; Steelman, Linda S; Long, Jacquelyn M; Kempf, Ruth C; Abrams, Stephen L; Franklin, Richard A; Baesecke, Joerg; Stivala, Franca; Donia, Marco; Fagone, Paolo;
Malaponte, Graziella; Mazzarino, Maria C; Nicoletti, Ferdinando; Libra, Massimo; Maksimović-Ivanić, Danijela
; Mijatović, Sanja ; Montalto, Giuseppe; Cervello, Melchiorre; Laidler, Piotr; Milella, Michele; Tafuri, Agostino; Bonati, Antonio; Evangelisti, Camilla; Cocco, Lucio; Martelli, Alberto M; McCubrey, James A; | Научна критика и полемика | 21M21 - Рад у врхунском међ. часопису |
| 2011 | Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging | Steelman, Linda S; Chappell, William H; Abrams, Stephen L; Kempf, C Ruth; Long, Jacquelyn M; Laidler, Piotr; Mijatović, Sanja ; Maksimović-Ivanić, Danijela ; Stivala, Franca; Mazzarino, Maria C;
Donia, Marco; Fagone, Paolo; Malaponte, Graziella; Nicoletti, Ferdinando; Libra, Massimo; Milella, Michele; Tafuri, Agostino; Bonati, Antonio; Baesecke, Joerg; Cocco, Lucio; Evangelisti, Camilla; Martelli, Alberto M; Montalto, Giuseppe; Cervello, Melchiorre; McCubrey, James A;
| Научна критика и полемика | 21M21 - Рад у врхунском међ. часопису |